Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/6XC stock hub

FRA/6XC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/6XCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/6XC
In the news

Latest news · FRA/6XC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E28.3
P25 n/aP50 n/aP75 n/a
ROE26.4
P25 n/aP50 n/aP75 n/a
ROIC35.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/6XC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
USD
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
182
Employees Change
60%
Employees Change Percent
65.22
Enterprise value
EUR 1.9B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 2.3B
Price
EUR 45.19
Price currency
EUR
Rev Per Employee
1,358,172.74x
Sic
2836
Symbol
fra/6XC
Website
https://soleno.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
3.54%
EV Earnings
23.41x
EV/EBIT
25.53x
EV/EBITDA
24.71x
EV/FCF
21.23x
EV/Sales
8.02x
FCF yield
3.9%
P/B ratio
5.45x
P/E ratio
28.27x
P/S ratio
9.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
31.4%
EBITDA Margin
32.11%
FCF margin
36.99%
Gross margin
98.63%
Gross Profit
EUR 243.8M
Net Income
EUR 82.9M
Pretax Margin
34.94%
Profit Margin
33.7%
Profit Per Employee
EUR 455,695
ROA
12.07
Roa5y
-31.4
ROCE
16.26
ROE
26.38
Roe5y
-79.29
ROIC
35.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
-27.42%
Cagr3y
135.23%
Cagr5y
28.35%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.62
Assets
EUR 527.7M
Cash
EUR 221.7M
Current Assets
EUR 276.8M
Current Liabilities
EUR 49.2M
Debt
EUR 47.1M
Debt EBITDA
EUR 0.59
Debt Equity
EUR 0.11
Debt FCF
EUR 0.51
Equity
EUR 430M
Interest Coverage
16.55
Liabilities
EUR 97.6M
Long Term Assets
EUR 250.9M
Long Term Liabilities
EUR 48.4M
Net Cash
EUR 411.7M
Net Cash By Market Cap
EUR 17.56
Net Cash Growth
100.17%
Net Debt EBITDA
EUR -5.19
Net Debt Equity
EUR -0.96
Net Debt FCF
EUR -4.5
Tangible Book Value
EUR 426.2M
Tangible Book Value Per Share
EUR 8.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
5.62
Net Working Capital
EUR 12M
Quick ratio
5.22
Working Capital
EUR 232.7M
Working Capital Turnover
EUR 0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-26.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-27.41%
200-day SMA
46.93
3Y total return
1,202.31%
50-day SMA
35.4
50-day SMA vs 200-day SMA
50under200
5Y total return
248.29%
All Time High
76.65
All Time High Change
-41.04%
All Time High Date
2025-07-31
All Time Low
0.82
All Time Low Change
5,410.98%
All Time Low Date
2022-12-16
ATR
1.14
Ch YTD
14.64
High
45.19
High52
76.65
High52 Date
2025-07-31
High52ch
-41.04%
Low
43.9
Low52
25.5
Low52 Date
2026-03-30
Low52ch
77.22%
Ma50ch
27.65%
Price vs 200-day SMA
-3.71%
RSI
72.92
RSI Monthly
51.97
RSI Weekly
55.91
Sharpe ratio
0.14x
Sortino ratio
0.28
Total Return
-26.81%
Tr YTD
14.64
Tr1m
47.01%
Tr1w
1.71%
Tr3m
35.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 77.6M
Operating margin
31.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
48,152,986%
Shares Insiders
1.28%
Shares Institutions
94.98%
Shares Qo Q
-2.33%
Shares Yo Y
26.81%
Short Ratio
1.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
EUR 50.5M
Average Volume
7.5x
Bv Per Share
8.31
CAPEX
EUR -93,668
Ch1m
47.01
Ch1w
1.71
Ch1y
-27.41
Ch3m
35.62
Ch3y
1,202.3
Ch5y
248.3
Ch6m
23.47
Change
2.1%
Change From Open
2.87
Close
44.26
Days Gap
-0.75
Depreciation Amortization
1,718,819
Earnings Date
2026-05-15
EBIT
EUR 77.6M
EBITDA
EUR 79.4M
EPS
EUR 1.53
F Score
4
FCF
EUR 91.4M
FCF EV Yield
4.71x
Financing CF
115,264,170
Fiscal Year End
December
Founded
1,999
Graham Number
17.26466
Graham Upside
-61.8
Income Tax
EUR 3.1M
Investing CF
-161,955,266
Is Primary Listing
0
Last Earnings Date
2026-02-25
Last Report Date
2026-03-31
Last Split Date
2022-08-26
Last Split Type
Reverse
Ma150
40.4
Ma150ch
11.86%
Ma20
42.72
Ma20ch
5.77%
Net CF
44,835,074
Next Earnings Date
2026-05-15
Open
43.93
P FCF Ratio
25.64
P OCF Ratio
25.62
Position In Range
100
Ppne
3,470,708.5
Price Date
2026-05-08
Price EBITDA
EUR 29.54
Ptbv Ratio
5.5
Relative Volume
16.36x
Revenue
247,187,438x
SBC By Revenue
16.57x
Share Based Comp
40,956,508
Tax By Revenue
1.24x
Tax Rate
3.55%
Tr6m
23.47%
Volume
0
Z Score
17.41
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/6XC pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/6XC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-27.4%
S&P 500 1Y: n/a
3Y total return
+1202.3%
S&P 500 3Y: n/a
5Y total return
+248.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/6XC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+95.0%
Share of float held by funds and institutions
Insider ownership
+1.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
1.7 days to cover
Y/Y dilution
+26.8%
Negative means the company is buying back shares.
Technical

FRA/6XC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
72.9
Above 70: short-term overbought
Price vs 200-day MA
-3.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.14
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/6XC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/6XC stock rating?

fra/6XC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/6XC analysis?

The full report lives at /stocks/fra/6XC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/6XC?

The latest report frames fra/6XC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/6XC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.